Sensata Technologies’ Cooperation Agreement with Elliott
April 30, 2024
On April 29, 2024, Sensata Technologies Holding plc (“Sensata Technologies”), a global industrial technology company, announced that it has entered into a Cooperation Agreement with Elliott Investment Management L.P. (“Elliott”). The Cooperation Agreement contains customary standstill, voting and other provisions. Cravath is representing Sensata Technologies in connection with the agreement.
The Cravath team is led by partners Richard Hall, Minh Van Ngo and Andrew M. Wark and includes associates Jessica E. Sandor and Asiya Jaffer and foreign associate attorney James Addison on corporate and activist defense matters.
Related Practices & Industries
People
- Photo
-
-
LL.M., 1988, Harvard Law School
-
LL.B., 1986, University of Melbournewith Honors
-
B.Com., 1984, University of Melbournewith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 2001, Yale Law School
-
B.A., 1998, Duke Universitysumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2013, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.S., 2010, Duke University
- New York
Education
Admitted In
Related News
Deals & Cases
April 04, 2024
Disney’s Successful Proxy Contest Against Trian and Blackwells
On April 3, 2024, The Walt Disney Company (“Disney”) announced that, based on the tabulation of its proxy solicitor, it appears that Disney’s full slate of 12 directors has been elected by a substantial margin over the nominees of Trian and Blackwells at Disney’s 2024 Annual Meeting of Shareholders. Cravath is representing Disney in connection with this matter.
Deals & Cases
May 25, 2023
Illumina’s Proxy Contest Against Carl Icahn
On May 25, 2023, Illumina, a global leader in DNA sequencing and array‑based technologies, announced that Illumina shareholders have voted to elect eight of nine Illumina director nominees to the Board of Directors. Cravath represented Illumina in connection with these matters.
Deals & Cases
February 14, 2023
Disney’s Successful Proxy Contest With Trian Fund
On February 9, 2023, The Walt Disney Company (“Disney”) issued a statement in response to Nelson Peltz’s announcement that Trian Fund is no longer pursuing a proxy contest at Disney. Cravath represented Disney in connection with this matter.
Deals & Cases
January 30, 2023
ViewRay’s Cooperation Agreement with Hudson Executive Capital
On January 20, 2023, ViewRay, Inc. (“ViewRay”), which designs, manufactures and markets the MRIdian® MRI‑Guided Radiation Therapy System, announced that it has reached an agreement with Hudson Executive Capital LP (“HEC”), a New York City‑based value‑oriented investor, to appoint a senior investment analyst and representative of HEC as an observer of the ViewRay Board of Directors (the “Board”), effective as of January 20, 2023. ViewRay has also agreed that the Board will appoint that observer to fill any vacancy on the Board arising during the term of the agreement. In connection with this announcement, ViewRay has also entered into a cooperation agreement with HEC, which currently owns approximately 8.7% of the Company’s outstanding common stock. Pursuant to its agreement with ViewRay, HEC has agreed to customary standstill and voting commitments, among other provisions. Cravath is representing ViewRay in connection with the agreement.
